Correlation Analysis of Interleukin-6 on Blood Glucose in Prediabetes and Normal Glycemic Status
AbstractDiabetes mellitus is a global health problem whose incidence rate continues to increase yearly. Most people with diabetes mellitus go through the prediabetes phase. Prediabetes is a condition where blood glucose levels are elevated but have not yet reached the criteria for diabetes mellitus. Low-grade chronic inflammation is one of the pathways known to interfere with insulin signalling that ultimately affects blood glucose levels. One of the most studied inflammatory pathways in the pathogenesis of diabetes mellitus is interleukin-6 (IL-6). This study aims to determine whether there were differences in IL-6 levels between groups of prediabetes subjects and normal subjects and to observe the correlation between IL-6 levels and blood glucose. This study is useful in providing additional scientific evidence on the development of diabetes mellitus, especially in blood glucose regulation through inflammatory pathways. The design of this study was analytic observational in 71 subjects with prediabetes or normal glycemic status. Prediabetes status was established based on fasting blood glucose levels and glucose levels 2 hours post oral glucose tolerance test. Subjects with fasting blood glucose levels> 125mg/ dl and who had a fever in the last week were excluded from the study. Interleukin 6 levels were measured based on the principle of enzyme-linked immunoassay. The correlation of interleukin 6 with glucose levels and other variables was analyzed using the spearmen test. The results showed that interleukin 6 levels did not differ between the prediabetes group and the normal group ((5.27 ± 2.55 pg/ml) vs (4.44 ± 2.46) respectively; (p=0.105)). There was no correlation between interleukin 6 level and fasting blood glucose level (r=0.014, p=0.908) and glucose level after the oral glucose tolerance test (r=-0.085, p=0.480). In this study, there was a significant correlation between body mass index with waist circumference (r=0.772, p=0.000) and glucose levels after the oral glucose tolerance test (r=0.240; p<0.001). Recommends the addition of anti-inflammatory cytokines and variable insulin to assess further the effect of the inflammatory process on the glucose metabolism of subjects in future studies.
Agarwal, A., Hegde, A., Yadav, C., Ahmad, A., Manjrekar, P. A., & Srikantiah, R. M. (2017). Association of Interleukin-6 and Myeloperoxidase with Insulin Resistance in Impaired Fasting Glucose Subjects. Indian Journal of Clinical Biochemistry, 32(1), 33–38. https://doi.org/10.1007/s12291-016-0567-8
Akbari, M., & Hassan-Zadeh, V. (2018a). Hyperglycemia Affects the Expression of Inflammatory Genes in Peripheral Blood Mononuclear Cells of Patients with Type 2 Diabetes. Immunological Investigations, 47(7), 654–665. https://doi.org/10.1080/08820139.2018.1480031
Akbari, M., & Hassan-Zadeh, V. (2018b). IL-6 signalling pathways and the development of type 2 diabetes. Inflammopharmacology, 26(3), 685–698. https://doi.org/10.1007/s10787-018-0458-0
Akbari, M., & Hassan-Zadeh, V. (2018c). Hyperglycemia Affects the Expression of Inflammatory Genes in Peripheral Blood Mononuclear Cells of Patients with Type 2 Diabetes. Immunological Investigations, 47(7), 654–665. https://doi.org/10.1080/08820139.2018.1480031
Akour, A., Kasabri, V., Bulatova, N., Muhaissen, S. Al, Naffa, R., Fahmawi, H., Momani, M., Zayed, A., & Bustanji, Y. (2017). Association of oxytocin with glucose intolerance and inflammation biomarkers in metabolic syndrome patients with and without prediabetes. Review of Diabetic Studies, 14(4), 364–371. https://doi.org/10.1900/RDS.2017.14.364
Alberti, S. G., Zimmet, P., Shaw, J., & Grundy, S. M. (2006). The IDF consensus worldwide definition of metabolic syndrome. In International Diabetes Federation.https://www.idf.org/component/attachments/attachments.html?id=705&task=download
Almuraikhy, S., Kafienah, W., Bashah, M., Diboun, I., Jaganjac, M., Al-Khelaifi, F., Abdesselem, H., Mazloum, N. A., Alsayrafi, M., Mohamed-Ali, V., & Elrayess, M. A. (2016). Interleukin-6 induces impairment in human subcutaneous adipogenesis in obesity-associated insulin resistance. Diabetologia, 59(11), 2406–2416. https://doi.org/10.1007/s00125-016-4031-3
Alwash, S. M., McIntyre, H. D., & Mamun, A. (2021). The association of general obesity, central obesity and visceral body fat with the risk of gestational diabetes mellitus: Evidence from a systematic review and meta-analysis. Obesity Research & Clinical Practice, 15(5), 425–430. https://doi.org/10.1016/j.orcp.2021.07.005
American Diabetes Association. (2022). Classification and Diagnosis of Diabetes : Standards of Medical Care in Diabetes — 2022. Diabetes Care, 45(Suppl), 17–38.
Badan Penelitian dan Pengembangan Kesehatan Kemenkes RI. (2018). Laporan Nasional Riskesdas 2018. In Balitbangkes. Lembaga Penerbit Balitbangkes. http://labdata.litbang.kemkes.go.id/images/download/laporan/RKD/2018/Laporan_Nasional_RKD2018_FINAL.pdf
Butkowski, E. G., Brix, L. M., Kiat, H., Al-Aubaidy, H., & Jelinek, H. F. (2016). Diabetes, oxidative stress and cardiovascular risk. Basic Research Journal of Medicine and Clinical Sciences, February. http://basicresearchjournals.org/medicine/mcsarch.html
Cho, N. H., Ku, E. J., Jung, K. Y., Oh, T. J., Kwak, S. H., Moon, J. H., Park, K. S., Jang, H. C., Kim, Y. J., & Choi, S. H. (2020). Estimated Association Between Cytokines and the Progression to Diabetes: 10-year Follow-Up From a Community-Based Cohort. Journal of Clinical Endocrinology and Metabolism, 105(3), 381–389. https://doi.org/10.1210/clinem/dgz171
De Filippo, G., Rendina, D., Moccia, F., Rocco, V., & Campanozzi, A. (2014). Interleukin-6, soluble interleukin-6 receptor/interleukin-6 complex and insulin resistance in obese children and adolescents. Journal of Endocrinological Investigation, 1–5. https://doi.org/10.1007/s40618-014-0176-4
Enga, F. S. (2013). Pengaruh diet tinggi karbohidrat terhadap jumlah neutrofil dan interleukin 6 (IL-6) pada tikus wistar jantan. Widya Mandala Catholic University Surabaya.
Hossain, M., Faruque, M. O., Kabir, G., Hassan, N., Sikdar, D., Nahar, Q., & Ali, L. (2010). Association of serum TNF-α and IL-6 with insulin secretion and insulin resistance in IFG and IGT subjects in a Bangladeshi population. International Journal of Diabetes Mellitus, 2(3), 165–168. https://doi.org/10.1016/j.ijdm.2010.08.004
Hu, H., Kawasaki, Y., Kuwahara, K., Nakagawa, T., Honda, T., Yamamoto, S., Eguchi, M., Kochi, T., Nishihara, A., Imai, T., Yamamoto, M., Okazaki, H., Miyamoto, T., Tomita, K., Uehara, A., Ogasawara, T., Sasaki, N., Hori, A., Nagahama, S., … Dohi, S. (2020). Trajectories of body mass index and waist circumference before the onset of diabetes among people with prediabetes. Clinical Nutrition (Edinburgh, Scotland), 39(9), 2881–2888. https://doi.org/10.1016/j.clnu.2019.12.023
Huang, K., Liang, Y., Ma, Y., Wu, J., Luo, H., & Yi, B. (2022). The Variation and Correlation of Serum Adiponectin, Nesfatin-1, IL-6, and TNF-α Levels in Prediabetes. Frontiers in Endocrinology, 13(March), 1–10. https://doi.org/10.3389/fendo.2022.774272
Itoh, H., Ueda, M., Suzuki, M., & Kohmura-Kobayashi, Y. (2022). Developmental Origins of Metaflammation; A Bridge to the Future Between the DOHaD Theory and Evolutionary Biology. Frontiers in Endocrinology, 13(February), 1–7. https://doi.org/10.3389/fendo.2022.839436
Kementrian Kesehatan Republik Indonesia. (2018). Hari Diabetes Sedunia Tahun 2018. Pusat Data Dan Informasi Kementrian Kesehatan RI, 1–8.
Lainampetch, J., Panprathip, P., Phosat, C., Chumpathat, N., Prangthip, P., Soonthornworasiri, N., Puduang, S., Wechjakwen, N., & Kwanbunjan, K. (2019). Association of Tumor Necrosis Factor Alpha, Interleukin 6, and C-Reactive Protein with the Risk of Developing Type 2 Diabetes: A Retrospective Cohort Study of Rural Thais. Journal of Diabetes Research, 2019, 9051929. https://doi.org/10.1155/2019/9051929
Lehrskov, L. L., & Christensen, R. H. (2019). The role of interleukin-6 in glucose homeostasis and lipid metabolism. Seminars in Immunopathology, 41(4), 491–499. https://doi.org/10.1007/s00281-019-00747-2
Li, X., Qiu, W., Li, N., Da, X., Ma, Q., Hou, Y., Wang, T., Song, M., & Chen, J. (2020). Susceptibility to Hyperglycemia in Rats With Stress-Induced Depressive-Like Behavior: Involvement of IL-6 Mediated Glucose Homeostasis Signaling. Frontiers in Psychiatry, 11(June), 1–13. https://doi.org/10.3389/fpsyt.2020.00557
Long, M.-H., Zhang, C., Xu, D.-Q., Fu, W.-L., Gan, X.-D., Li, F., Wang, Q., Xia, W., & Xu, D.-G. (2020). PM(2.5) aggravates diabetes via the systemically activated IL-6-mediated STAT3/SOCS3 pathway in rats’ liver. Environmental Pollution (Barking, Essex : 1987), 256, 113342. https://doi.org/10.1016/j.envpol.2019.113342
Lopez, Y. O. N., Garufi Gabriella, & Seyhan, A. A. (2017). Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes. Molecular BioSystems, 13(1), 106–121. https://doi.org/10.1039/c6mb00596a
Nisr, R. B., Shah, D. S., Ganley, I. G., & Hundal, H. S. (2019). Proinflammatory NFkB signalling promotes mitochondrial dysfunction in skeletal muscle in response to cellular fuel overloading. Cellular and Molecular Life Sciences, 76(24), 4887–4904. https://doi.org/10.1007/s00018-019-03148-8
Perkumpulan Endokriologi Indonesia. (2021). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia. In PB Perkeni. PB Perkeni.
Persatuan Diabetes Indonesia, & Perkumpulan Endokriologi Indonesia. (2019). Pedoman pengolaan dan pencegahan prediabetes di Indonesia 2019. In Surabaya.
Phosat, C., Panprathip, P., Chumpathat, N., Prangthip, P., Chantratita, N., Soonthornworasiri, N., Puduang, S., & Kwanbunjan, K. (2017). Elevated C-reactive protein, interleukin 6, tumor necrosis factor alpha and glycemic load associated with type 2 diabetes mellitus in rural Thais: A cross-sectional study. BMC Endocrine Disorders, 17(1), 1–8. https://doi.org/10.1186/s12902-017-0189-z
Randeria, S. N., Thomson, G. J. A., Nell, T. A., Roberts, T., & Pretorius, E. (2019). Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation. Cardiovascular Diabetology, 1–15. https://doi.org/10.1186/s12933-019-0870-9
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., Shaw, J. E., Bright, D., & Williams, R. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Research and Clinical Practice, 157, 107843. https://doi.org/10.1016/j.diabres.2019.107843
Snehalatha, C., Satyavani, K., Sivasankari, S., Vijay, V., & Ramachandran, A. (2017). Insulin secretion and action in different stages of glucose tolerance in Asian Indians. Diabetic Medicine, 16(5), 408–414. https://doi.org/https://doi.org/10.1046/j.1464-5491.1999.00084.x
Valaiyapathi, B., Gower, B., & Ashraf, A. P. (2020). Pathophysiology of Type 2 Diabetes in Children and Adolescents. Current Diabetes Reviews, 16(3), 220–229. https://doi.org/10.2174/1573399814666180608074510
Weaver, J. R., Odanga, J. J., Breathwaite, E. K., Treadwell, M. L., Murchinson, A. C., Walters, G., Fuentes, D. P., & Lee, J. B. (2021). An increase in inflammation and islet dysfunction is a feature of prediabetes. Diabetes/Metabolism Research and Reviews, 37(6), e3405. https://doi.org/https://doi.org/10.1002/dmrr.3405
World Health Organization. (2006). Definition and diagnosis of diabetes mellitus and intermediate hyperglicaemia: report of a WHO/IDF consultation. In World Health Organization. WHO press.
World Health Organization. (2016). Global Report on Diabetes. In WHO (Vol. 978). https://www.who.int/publications/i/item/9789241565257
World Health Organization. (2021). Diabetes - Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/diabetes
Zhuravlyova, L., Sokolnikova, N., Filonenko, M., & Rogachova, T. (2019). Interleukin-1β and interleukin-6 - a new markers of metabolic disorders in diabetes mellitus type 2. Georgian medical news, 287, 82–87.
How to Cite
Copyright (c) 2023 Ratih Feraritra Danu Atmaja, Theosobia Grace Orno, Tuty Yuniarty, Handayani Malik
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Publishing your paper with Medical Laboratory Technology Journal (MLTJ) means that the author or authors retain the copyright in the paper. MLTJ granted an author(s) rights to put the paper onto a website, distribute it to colleagues, give it to students, use it in your thesis etc, even commercially. The author(s) can reuse the figures and tables and other information contained in their paper published by MLTJ in future papers or work without having to ask anyone for permission, provided that the figures, tables or other information that is included in the new paper or work properly references the published paper as the source of the figures, tables or other information, and the new paper or work is not direct at private monetary gain or commercial advantage.
MLTJ journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets others remix, transform, and build upon the material for any purpose, even commercially. MLTJ journal Open Access articles are distributed under this Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA). Articles can be read and shared for All purposes under the following conditions:
BY: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.SA: If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.